Patent · US Active

Combination of triazine derivatives and insulin sensitisers

US8791115B2 · kind B2 · utility

4Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2006
Grant dateJul 29, 2014
Priority date
Expiry dateOct 27, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to combinations of triazine derivatives and of insulin sensitizers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.